These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35678839)

  • 1. Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic with implementation of patients' masking.
    Mirghorbani M; Bazvand F; Riazi-Esfahani H; Bahar MM; Yaseri M; Zarei M
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3657-3664. PubMed ID: 35678839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ
    Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PATIENT-PHYSICIAN FACE MASKING'S INFLUENCE ON THE POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS.
    Liddle C; Capone A; Trese M
    Retina; 2024 Jul; 44(7):1203-1208. PubMed ID: 38363792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections.
    Hébert M; You E; Hammamji K; Bourgault S; Caissie M; Tourville É; Dirani A
    Can J Ophthalmol; 2022 Dec; 57(6):364-369. PubMed ID: 34419421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS DURING THE COVID-19 PANDEMIC WITH IMPLEMENTATION OF UNIVERSAL MASKING.
    Naguib MM; Ghauri S; Mukhopadhyay A; Schefler AC
    Retina; 2021 Nov; 41(11):2208-2214. PubMed ID: 33958531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection.
    Neubauer J; Gklavas K; Kortüm F; Gosheva M; Bartz-Schmidt KU; Ziemssen F
    Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):97-102. PubMed ID: 35932321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Risk Factors for Post-Intravitreal Injection Endophthalmitis in a Modified Operating Room Setting.
    Zarei M; Karkhaneh R; Mahmoudzadeh R; Salabati M; Nabavi A; Yaseri M; Najibzadeh E; Roohipoor R; Riazi Esfahani M; Khodabande A; Ghassemi F; Ebrahimiadib N; Khojasteh H; Modjtahedi BS
    Ocul Immunol Inflamm; 2019; 27(8):1314-1321. PubMed ID: 30303423
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center.
    Gonzalez-Gonzalez LA; Knickelbein JE; Doft BH; Balasubramani GK; Wisniewski S
    Int Ophthalmol; 2023 Mar; 43(3):867-876. PubMed ID: 36103102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.
    Bavinger JC; Yu Y; VanderBeek BL
    Retina; 2019 Oct; 39(10):2004-2011. PubMed ID: 30312260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.
    Casparis H; Wolfensberger TJ; Becker M; Eich G; Graf N; Ambresin A; Mantel I; Michels S
    Retina; 2014 Jan; 34(1):12-7. PubMed ID: 23945639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.
    Pancholy M; Storey PP; Levin HJ; Obeid A; Patel SN; Kuley B; Hsu J; Spirn MJ; Fineman M; Klufas MA; Gupta O; Ho AC; Garg SJ
    Curr Eye Res; 2021 Sep; 46(9):1370-1377. PubMed ID: 33522314
    [No Abstract]   [Full Text] [Related]  

  • 12. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
    Freiberg FJ; Brynskov T; Munk MR; Sørensen TL; Wolf S; Wirth MA; Becker M; Michels S
    Retina; 2017 Dec; 37(12):2341-2346. PubMed ID: 28099318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endophthalmitis after resident-performed intravitreal bevacizumab injection.
    Falavarjani KG; Aghamirsalim M; Modarres M; Hadavandkhani A; Hashemi M; Parvaresh MM; Naseripour M; Samiy N
    Can J Ophthalmol; 2015 Feb; 50(1):33-6. PubMed ID: 25677280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis.
    Garg SJ; Dollin M; Hsu J; Storey P; Vander JF
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1028-34. PubMed ID: 26599245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pandemic Is Not Associated with Endophthalmitis Decrease after Anti-Vascular Endothelial Growth Factor Injections.
    Lum F; Li S; Liu L; Li C; Parke DW; Williams GA
    Ophthalmology; 2022 Jun; 129(6):719-721. PubMed ID: 35041903
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative Study of Microbiological Profile and Management Outcomes of Acute Endophthalmitis after Microincision Vitrectomy Surgery versus Intravitreal Injections.
    Kannan NB; Sen S; Mishra C; Lalitha P; Rameshkumar G; Rajan RP; Arumugam KK; Ramasamy K
    Ocul Immunol Inflamm; 2021 Jul; 29(5):838-844. PubMed ID: 31900009
    [No Abstract]   [Full Text] [Related]  

  • 17. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ;
    Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Endophthalmitis after Intravitreal Bevacizumab using Aliquots Prepared On-site in 2 Operating Rooms in Kuwait.
    Wani VB; Al-Kandari J; Sabti K; Aljassar F; Qali H; Kumar N; Uboweja A; Al-Sabah K; Diab FA; Al-Rashidi S
    Middle East Afr J Ophthalmol; 2016; 23(1):64-70. PubMed ID: 26957841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections: A multicentric study.
    Sen S; Mishra C; Kannan NB; Ramasamy K; Rameshkumar G; Lalitha P
    Semin Ophthalmol; 2021 Aug; 36(5-6):413-422. PubMed ID: 33750261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EFFECT OF PHYSICIAN FACE MASK USE ON POSTINJECTION ENDOPHTHALMITIS.
    Fortes BH; Astafurov KV; Hodge DO; Smith WM; Barkmeier AJ; Olsen TW; Iezzi R; Bakri SJ
    Retina; 2022 Nov; 42(11):2120-2127. PubMed ID: 35963006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.